Formulation optimization and characterization of chitosan based nanoparticles containing sulfasalazine and methylprednisolone for the treatment of inflammatory bowel disease

dc.contributor.guide	Sharma, Ganesh N
dc.coverage.spatial	223
dc.creator.researcher	Kumar, Chembeti Praveen
dc.date.accessioned	2021-10-04T09:28:32Z
dc.date.available	2021-10-04T09:28:32Z
dc.date.awarded
dc.date.completed	2020
dc.date.registered
dc.description.abstract	newline
dc.description.note
dc.format.accompanyingmaterial	DVD
dc.format.dimensions
dc.format.extent	223 Pages
dc.identifier.uri	http://hdl.handle.net/10603/343034
dc.language	English
dc.publisher.institution	Department of Pharmaceutical Sciences
dc.publisher.place	Jaipur
dc.publisher.university	Jaipur National University
dc.relation
dc.rights	university
dc.source.university	University
dc.subject.keyword	Clinical Pre Clinical and Health
dc.subject.keyword	Pharmacology and Pharmacy
dc.subject.keyword	Pharmacology and Toxicology
dc.title	Formulation optimization and characterization of chitosan based nanoparticles containing sulfasalazine and methylprednisolone for the treatment of inflammatory bowel disease
dc.title.alternative	Formulation optimization and characterization of chitosan based nanoparticles containing sulfasalazine and methylprednisolone for the treatment of inflammatory bowel disease
dc.type.degree	Ph.D.